MedTrace Logo

Adherence With Iron Sprinkles Among High-Risk Infants

NCT00136266 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2016-02-03

No results posted yet for this study

Summary

Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.

Conditions

Interventions

DRUG

Ferrous sulphate drops with vitamins A, D, and C

DRUG

Ferrous fumarate sprinkles with vitamins and minerals

Sponsors & Collaborators

Principal Investigators

  • Paul L. Geltman, MD, MPH · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Months
Max Age
7 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00136266 on ClinicalTrials.gov